Stay updated with breaking news from Advanced Heart Failure Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The first U.S. heart patient involved in a study for a new gene-editing therapy directly infused inside the body has successfully been enrolled at MedStar Washington Hospital Center.
Study examines if gene editing can help people living with transthyretin amyloidosis with cardiomyopathy (ATTR-CM) WASHINGTON, May 2, 2024 /PRNewswire/ -- The...
The first U.S. heart patient involved in a study for a new gene-editing therapy has successfully been treated at MedStar Washington Hospital Center.
The first U.S. heart patient involved in a study for a new gene-editing therapy has successfully been treated at MedStar Washington Hospital Center.
The center announced Monday it completed 61 adult heart transplants in 2023, breaking its previous record set in 2016 by five procedures.